Filter News
Area of Research
- (-) Neutron Science (19)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (1)
- Biological Systems (1)
- Biology and Environment (10)
- Clean Energy (29)
- Computer Science (1)
- Isotope Development and Production (1)
- Isotopes (1)
- Materials (35)
- Materials for Computing (2)
- National Security (7)
- Quantum information Science (1)
- Supercomputing (22)
News Topics
- (-) Bioenergy (5)
- (-) Biomedical (6)
- (-) Coronavirus (6)
- (-) Materials Science (11)
- (-) National Security (1)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (5)
- Artificial Intelligence (1)
- Big Data (1)
- Clean Water (1)
- Climate Change (1)
- Computer Science (9)
- Decarbonization (1)
- Energy Storage (2)
- Environment (4)
- Fusion (7)
- Isotopes (2)
- Machine Learning (2)
- Mathematics (1)
- Microscopy (1)
- Nanotechnology (4)
- Neutron Science (31)
- Nuclear Energy (19)
- Physics (4)
- Polymers (1)
- Quantum Science (2)
- Space Exploration (3)
- Summit (5)
- Sustainable Energy (2)
- Transformational Challenge Reactor (3)
- Transportation (1)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.
For more than 50 years, scientists have debated what turns particular oxide insulators, in which electrons barely move, into metals, in which electrons flow freely.